Testing effectiveness (Phase 2)Study completedNCT00126594
What this trial is testing
Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 80